Centenial Surgical Suture Ltd

AGM details

• Date: 28-09-2026; Start 02:00 PM, end 02:25 PM.
• Mode: VC/OAVM; record date 21-09-2026; shareholders on record 1,203.
• Shareholders attending via videoconference: promoters 3, public 22.

Resolutions placed

• Item 1: Adopt audited financial statements; ordinary; passed.
• Item 2: Appoint director in place of Kashikar (rotating); ordinary; passed.
• Item 3: Re-appoint Kashikar as Executive Director; ordinary; passed; her votes invalid.

Voting outcomes

• Resolution 1 passed; 100% in favour.
• Resolution 2 passed; 99.99% in favour, 0.01% against.
• Resolution 3 passed; majority; Kashikar’s votes treated as invalid.

Dividend

• Dividend information is not disclosed in the filing.

Director changes

• Anuradha Kashikar appointed as Director (retiring by rotation) and reappointed as Executive Director.

Auditors

• No auditor appointments or changes disclosed.

Material related party transactions

• No material related party transactions disclosed.

Other material approvals

• No other material approvals reported.

AGM details

• Date: 28 Sep 2026; Time: 2:00 PM; Mode: VC/OAVM; Record date: 21 Sep 2026.

Resolutions proposed

• Ordinary: To receive, consider and adopt the Audited Financial Statements for the year ended 31 March 2026.
• Ordinary: To appoint Ms Anuradha Kashikar (DIN 00804831) as Director by rotation, eligible for re-appointment.
• Ordinary: Re-appointment of Anuradha Kashikar as Executive Director.

Voting results

• Item 1 passed: Audited financials adopted; unanimous in-favour.
• Item 2 passed: Director appointment by rotation; 99.99% in favour.
• Item 3 passed: Re-appointment of Anuradha Kashikar as Executive Director; 59.17% in favour; 698,500 invalid votes.

Dividend

• Dividend: No dividend proposed or declared.

Director changes

• Re-appointment of Anuradha Kashikar as Executive Director; she continues as Director.

Auditors

• Auditors: No changes to statutory, secretarial, or cost auditors announced.

Material related party transactions

• Material RPTs: none disclosed.

Other material approvals

• Other approvals: None reported.

Centenial Surgical Suture Ltd trading window closed from Thursday, October 1, 2026 until 48 hours after the Financial Results for the quarter and half year ended September 30, 2026 have been disseminated to the stock exchange

CFO resignation and transition

• Name of resigning CFO: Anuradha Kashikar.
• Last working day: 14 August 2026.
• Reason for resignation: Personal reasons.
• No other material reasons for resignation stated.
• Board has accepted the resignation and taken on record.
• Sapna Mhatre appointed CFO effective 14 August 2026; previously CAO.

Financial snapshot

• Revenue from operations: Rs 5,384.02 Lakhs.
• Net loss after tax: Rs (220.46) Lakhs for 2025-26.
• Net profit before tax: Rs (208.34) Lakhs; depreciation Rs 399.88 Lakhs.
• Total assets: Rs 7,978.70 Lakhs; equity: Rs 2,855.03 Lakhs.

Operations & product

• Manufactures sterile atraumatic sutures; started surgical threads production.
• Two new medical device codes under development and trials.
• Capacity utilisation described as satisfactory; focus on input-cost reductions.
• Quality certifications: ISO 9001:2015, ISO 13485:2016, WHO-GMP.

Market and outlook

• Industry faces intense domestic and international competition; demand expected to remain stable medium term.
• Backward integration to reduce thread raw material dependency; scale production in 2026-27.
• Investing in cost savings and portfolio transformation; monitor commodities and currency moves.

Capital structure & liquidity

• Paid-up capital: Rs 364.83 Lakhs; reserves: Rs 2,312.60 Lakhs.
• Current borrowings: Rs 1,070.90 Lakhs; total liabilities: Rs 5,123.67 Lakhs.
• Cash on hand: Rs 20.17 Lakhs; no long-term debt disclosed.
• Dematerialised shares: 93.04%; physical: 6.96%.

Governance

• Board strength: 7 directors; 4 Independent; 2 Women on board.
• Board met 5 times in 2025-26; independent directors met separately.
• Committees: Audit, Nomination & Remuneration, Stakeholders Relationship.
• Secretarial audit: no qualifications; CRISIL rating maintained.

Risks & regulatory

• Pricing pressure and regulatory challenges; supply chain risk.
• Currency and commodity volatility; potential margin impact.
• Regulatory risk in medical devices; ongoing litigation risk monitored.

Shareholder information

• Promoters hold 83.12% of equity; Majrekar and Kashikar major holders.
• Stock listed on BSE; ISIN INE405H01018; IPO price Rs 10 in 1996.
• 31 Mar 2026 closing price Rs 76.27; market cap Rs 27.83 Crores.

Audits & compliance

• Statutory auditors: Mahesh Chandra & Associates; Secretarial: HSPN & Associates LLP.
• No frauds reported; internal controls assessed as adequate.

AGM Details

• 31st e-AGM on Sep 28, 2026 at 2:00 PM via VC/OAVM
• Register of Members & Share Transfer Books closed Sep 22–28, 2026

Ordinary Business

• Adoption of Audited Accounts for year ended Mar 31, 2026
• Appointment of Anuradha Kashikar as Director by rotation

Special Business

• Re-appointment of Anuradha Kashikar as Executive Director for 3 years

ED Terms & Rationale

• Annexure I states NIL remuneration for ED re-appointment

Voting & Notice

• Remote e-voting opens Sep 24, 2026 and closes Sep 27, 2026
• Voting cut-off date: Sep 21, 2026
• Proxies not permitted for the 31st e-AGM

AGM notice and regulatory reminders

• 31st e-AGM via VC/OAVM on September 28, 2026 at 2:00 PM IST.
• Shareholders without registered emails will receive a web-link to the Annual Report.
• Annual Report 2025-2026 available online; PDF path: https://centenialindia.com/wp-content/uploads/2026/08/ANNUAL-REPORT-20252026.pdf
• Benpos date for notices: August 28, 2026.
• KYC updates and nomination details required under SEBI circular; Purva forms ISR/SH available.

AGM Details

• 31st AGM scheduled for 28 September 2026 at 2:00 PM IST via video conferencing.
• Cut-off date for voting eligibility: 21 September 2026.
• Remote e-voting from Sep 24, 2026, 9:00 AM to Sep 27, 2026, 5:00 PM IST.